These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 24685574)

  • 21. A possible step made towards a desired blood test for Alzheimer's disease.
    McGuinness L
    Biomark Med; 2012 Oct; 6(5):639. PubMed ID: 23233920
    [No Abstract]   [Full Text] [Related]  

  • 22. Creatininium reference intervals for corrected methods.
    Mårtensson A; Rustad P; Lund H; Ossowicki H
    Scand J Clin Lab Invest; 2004; 64(4):439-41. PubMed ID: 15223706
    [No Abstract]   [Full Text] [Related]  

  • 23. Microextraction by packed sorbent for LC-MS/MS determination of drugs in whole blood samples.
    Said R; Kamel M; El-Beqqali A; Abdel-Rehim M
    Bioanalysis; 2010 Feb; 2(2):197-205. PubMed ID: 21083303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood lead analysis - precision and stability.
    Lerner S
    J Occup Med; 1975 Mar; 17(3):153-4. PubMed ID: 1123684
    [No Abstract]   [Full Text] [Related]  

  • 25. Fluorimetric estimation of the concentration of NADH from human blood samples.
    Uppal A; Ghosh N; Datta A; Gupta PK
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):43-7. PubMed ID: 15035655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer.
    Koch CD; Wockenfus AM; Saenger AK; Jaffe AS; Karon BS
    Clin Biochem; 2012 Jul; 45(10-11):842-4. PubMed ID: 22561083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [RiliBAK--a new computation concept].
    Bauersfeld W
    Clin Lab; 2006; 52(11-12):689-94. PubMed ID: 17175897
    [No Abstract]   [Full Text] [Related]  

  • 28. Differences in glucose values obtained from point-of-care glucose meters and laboratory analysis in critically ill patients.
    Cook A; Laughlin D; Moore M; North D; Wilkins K; Wong G; Wallace-Scroggs A; Halvorsen L
    Am J Crit Care; 2009 Jan; 18(1):65-71; quiz 72. PubMed ID: 19116407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical effects of chronic increased lead absorption--a prospective study. I. Study design and analysis of symptoms.
    Spivey GH; Brown CP; Baloh RW; Campion DS; Valentine JL; Massey FJ; Browdy BL; Culver BD
    J Occup Med; 1979 Jun; 21(6):423-9. PubMed ID: 475890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood lead screening practices among US pediatricians.
    Campbell JR; Schaffer SJ; Szilagyi PG; O'Connor KG; Briss P; Weitzman M
    Pediatrics; 1996 Sep; 98(3 Pt 1):372-7. PubMed ID: 8784359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcutaneous bilirubinometry in neonates.
    Faridi MM
    Indian Pediatr; 1998 Jun; 35(6):568-9. PubMed ID: 10216661
    [No Abstract]   [Full Text] [Related]  

  • 32. Elevated blood lead levels in urban moonshine drinkers.
    Morgan BW; Todd KH; Moore B
    Ann Emerg Med; 2001 Jan; 37(1):51-4. PubMed ID: 11145771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical performance of an enzymatic cycling method for total homocysteine measurement.
    Jin M; Wang F; Uthup M; Szydlowska M
    Clin Chim Acta; 2009 Jan; 399(1-2):119-20. PubMed ID: 18840421
    [No Abstract]   [Full Text] [Related]  

  • 34. [A reliable and rapid method for the determination of lead in small quantities of blood].
    Lehnert G; Schaller KH; Szadkowski D
    Z Klin Chem Klin Biochem; 1969 May; 7(3):310. PubMed ID: 5356501
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of children at risk for lead poisoning: an evaluation of routine pediatric blood lead screening in an HMO-insured population.
    Haan MN; Gerson M; Zishka BA
    Pediatrics; 1996 Jan; 97(1):79-83. PubMed ID: 8545230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
    Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
    Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interlaboratory evaluation of the reliability of blood lead analyses.
    Keppler JK; Maxfield ME; Moss WD; Tietjen G; Linch AL
    Am Ind Hyg Assoc J; 1970; 31(4):412-29. PubMed ID: 5473751
    [No Abstract]   [Full Text] [Related]  

  • 38. The interlaboratorial quality assurance program for blood lead determination. An evaluation of methods and results.
    Morisi G; Patriarca M; Taggi F
    Ann Ist Super Sanita; 1989; 25(3):405-15. PubMed ID: 2624352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analytical false-positive increases and cardiac troponin I: what is the best sample?].
    Grenier A
    Ann Biol Clin (Paris); 2009; 67(1):118-20. PubMed ID: 19278053
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulatory antioxidant enzymes.
    Pippenger CE; Browne RW; Armstrong D
    Methods Mol Biol; 1998; 108():299-313. PubMed ID: 9921539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.